Showing results (11-20 of 20) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Journal of Cancer|November 21, 2017
Diagnostic Accuracy of a CA125-Based Biomarker Panel in Patients with Pancreatic Cancer: A Systematic Review and Meta-AnalysisQingcai Meng, Si Shi, Chen Liang, et al.Molecular Cancer Research : MCR|January 22, 2017
Oncogenic KRAS Targets MUC16/CA125 in Pancreatic Ductal AdenocarcinomaChen Liang, Yi Qin, Bo Zhang, et al.Cell Proliferation|April 28, 2018
dCK negatively regulates the NRF2/ARE axis and ROS production in pancreatic cancerQiangsheng Hu, Yi Qin, Jinfeng Xiang, et al.Biochimica Et Biophysica Acta|September 8, 2016
Metabolic plasticity in heterogeneous pancreatic ductal adenocarcinomaChen Liang, Yi Qin, Bo Zhang, et al.Cancer Letters|December 28, 2016
ARF6, induced by mutant Kras, promotes proliferation and Warburg effect in pancreatic cancerChen Liang, Yi Qin, Bo Zhang, et al.Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|December 10, 2024
WDR36 Regulates Trophectoderm Differentiation During Human Preimplantation Embryonic Development Through Glycolytic MetabolismShiyu An, Shuyue Hou, Feifei Xu, et al.Cell Death & Disease|February 25, 2018
TCF7L2 positively regulates aerobic glycolysis via the EGLN2/HIF-1α axis and indicates prognosis in pancreatic cancerJinfeng Xiang, Qiangsheng Hu, Yi Qin, et al.Acta Biochimica Et Biophysica Sinica|September 22, 2016
Energy sources identify metabolic phenotypes in pancreatic cancerChen Liang, Yi Qin, Bo Zhang, et al.International Journal of Oncology|March 29, 2017
A new facet of NDRG1 in pancreatic ductal adenocarcinoma: Suppression of glycolytic metabolismWensheng Liu, Bo Zhang, Qiangsheng Hu, et al.International Journal of Oncology|January 1, 2016
The clinical utility of CA125/MUC16 in pancreatic cancer: A consensus of diagnostic, prognostic and predictive updates by the Chinese Study Group for Pancreatic Cancer (CSPAC)Liang Liu, Jinfeng Xiang, Rufu Chen, et al.Pageof 2